These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 19406269)

  • 1. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
    Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
    Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure.
    Moorjani N; Ahmad M; Catarino P; Brittin R; Trabzuni D; Al-Mohanna F; Narula N; Narula J; Westaby S
    J Am Coll Cardiol; 2006 Oct; 48(7):1451-8. PubMed ID: 17010810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
    Kong YH; Li WM; Tian Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy.
    Di Napoli P; Taccardi AA; Grilli A; Felaco M; Balbone A; Angelucci D; Gallina S; Calafiore AM; De Caterina R; Barsotti A
    Am Heart J; 2003 Dec; 146(6):1105-11. PubMed ID: 14661007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats.
    Ikeda S; Hamada M; Hiwada K
    Clin Sci (Lond); 1999 Aug; 97(2):239-46. PubMed ID: 10409480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats.
    Ikeda S; Hamada M; Qu P; Hiasa G; Hashida H; Shigematsu Y; Hiwada K
    Clin Sci (Lond); 2002 Mar; 102(3):329-35. PubMed ID: 11869174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes.
    Fabris B; Candido R; Bortoletto M; Zentilin L; Sandri M; Fior F; Toffoli B; Stebel M; Bardelli M; Belgrado D; Giacca M; Carretta R
    J Hypertens; 2007 Jul; 25(7):1481-90. PubMed ID: 17563572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure.
    Pawlak A; Gil RJ; Kasprzak J; Walczak E; Słysz A
    Kardiol Pol; 2009 Jul; 67(7):724-33. PubMed ID: 19649994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death.
    Elsässer A; Vogt AM; Nef H; Kostin S; Möllmann H; Skwara W; Bode C; Hamm C; Schaper J
    J Am Coll Cardiol; 2004 Jun; 43(12):2191-9. PubMed ID: 15193679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy.
    Vanderheyden M; Paulus WJ; Voss M; Knuefermann P; Sivasubramanian N; Mann D; Baumgarten G
    Heart; 2005 Jul; 91(7):926-31. PubMed ID: 15958363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon.
    Aharinejad S; Andrukhova O; Lucas T; Zuckermann A; Wieselthaler G; Wolner E; Grimm M
    Ann Thorac Surg; 2008 Jul; 86(1):109-14; discussion 114. PubMed ID: 18573408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure.
    Dewachter C; Dewachter L; Rondelet B; Fesler P; Brimioulle S; Kerbaul F; Naeije R
    Crit Care Med; 2010 Jun; 38(6):1405-13. PubMed ID: 20431484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes.
    Fortunato SJ; Menon R; Bryant C; Lombardi SJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1468-76. PubMed ID: 10871467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix.
    Adhya AK; Srinivasan R; Patel FD
    Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device.
    Prescimone T; Masotti S; D'Amico A; Caruso R; Cabiati M; Caselli C; Viglione F; Verde A; Del Ry S; Giannessi D
    Cardiovasc Pathol; 2014; 23(5):272-82. PubMed ID: 24856512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.